Effects of a Health Intervention on Fear of Hypoglycemia
Effects of a Health Education Intervention Based on the Behaviour Change Wheel on Fear of Hypoglycemia in Patients With Type 2 Diabetes Mellitus: a Randomized Controlled Study
1 other identifier
interventional
90
1 country
1
Brief Summary
To examine the effects of a health Education Intervention based on the Behaviour Change Wheel (BCW) theory on fear of hypoglycemia and relevant outcomes of type 2 diabetic patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 13, 2024
CompletedFirst Posted
Study publicly available on registry
June 18, 2024
CompletedStudy Start
First participant enrolled
July 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2025
CompletedJuly 9, 2024
July 1, 2024
6 months
June 13, 2024
July 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hypoglycemia fear survey
Fear of hypoglycemia (FoH) was assessed using the Hypoglycemic Fear Survey Scale (HFS), which consists of two subscales, the Hypoglycemic Fear Survey- Behavioral Scale (HFS-BS) and the Hypoglycemic Fear Survey-Worry Scale (HFS-WS). (1) The HFS-BS scale has 19 entries, using a 5-point Likert scale, with scores ranging from 1 \~ 5 in descending order, and a total score of 15 \~ 95, with higher scores indicating more obvious hypoglycemic fearful behaviors in patients. (2) HFS-WS has 13 entries, which were scored using a 5-point Likert scale, with scores ranging from 0 to 4 from low to high, and a total score of 0 \~ 52. The higher the score, the higher the degree of fear of hypoglycemia in patients. The two subscale scores were added together, and the higher the total score, the more severe the fear of hypoglycemia.
Baseline, 4 and 12 weeks post-intervention
Secondary Outcomes (3)
Gold Rating
Baseline, 4 and 12 weeks post-intervention
The Patients Assessment Chronic Illness Care( PACIC)
Baseline, 4 and 12 weeks post-intervention
The self-management attitude scale for diabetes patients
Baseline, 4 and 12 weeks post-intervention
Study Arms (2)
Routine Care
PLACEBO COMPARATORImplementation of routine diabetes health education.
Based on BCW Theory of Health Education
EXPERIMENTALA FoH intervention program based on BCW theory was implemented on top of the routine care.
Interventions
Provide patients with regular medication guidance, dietary guidance, exercise guidance and knowledge about diabetes mellitus and hypoglycaemia; test and record blood glucose regularly every day; answer patients' clinical questions and provide psychological support in a timely manner.
BCW theory was applied to analyse behaviour and develop interventions in terms of capability, motivation and opportunity. Capability: Intensive daily management of diabetes through intervention functions (education, training, persuasion, modelling) to change attitudes and habits, understand the negative consequences of fear of hypoglycaemia, improve hypoglycaemia awareness and self-regulation skills. Opportunity: Through the intervention function (education, training, realization) to improve the awareness of hypoglycemia awareness, timely detection of hypoglycemia. In the event of a hypoglycaemic event patients know how to deal with it. Motivation: Through intervention functions (environmental reconstruction, realisation) that take full account of external factors and their own opportunities. Glucose management through microsoft platforms, on-site teaching and coaching by specialist nurses to create opportunities for patients who can change excessive/avoidant behaviours.
Eligibility Criteria
You may qualify if:
- Comply with the 2020 Chinese guidelines for the prevention and treatment of type 2 diabetes mellitus;
- Age ≥18 years;
- Duration of diabetes mellitus ≥1 year;
- FoH according to the elevated item endorsement criterion (E I criterion): ≥3 points on any item of the Hypoglycemic Fear-Worry Scale (HFS-WS);
- Patients who have the ability to listen, read, write, walk, and cooperate to complete the study;
- Patients who have a smart phone, and can skillfully use WeChat or telephone to communicate;
- Voluntarily participate in this study and sign the informed consent form.
You may not qualify if:
- Patients with comorbid acute complications or other serious diseases or disorders of consciousness, such as diabetic hypertonic state, tumors, coma, etc;
- Patients with comorbid psychiatric diseases or taking psychotropic drugs;
- Patients who have recently or are participating in other studies on similar topics.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Yangzhou University
Yangzhou, Jiangsu, 225000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhao Yueqi, Master
Yangzhou University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 13, 2024
First Posted
June 18, 2024
Study Start
July 1, 2024
Primary Completion
January 1, 2025
Study Completion
January 1, 2025
Last Updated
July 9, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share